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Multidrug resistance (MDR) remains a primary hindrance to curative cancer therapy. Thus, introduction of novel strategies
to overcome MDR is of paramount therapeutic signiﬁcance. Sequestration of chemotherapeutics in lysosomes is an established
mechanism of drug resistance. Here, we show that MDR cells display a marked increase in lysosome number. We further
demonstrate that imidazoacridinones (IAs), which are cytotoxic ﬂuorochromes, undergo a dramatic compartmentalization in
lysosomes because of their hydrophobic weak base nature. We hence developed a novel photoactivation-based
pharmacological Trojan horse approach to target and eradicate MDR cancer cells based on photo-rupture of IA-loaded
lysosomes and tumor cell lysis via formation of reactive oxygen species. Illumination of IA-loaded cells resulted in lysosomal
photodestruction and restoration of parental cell drug sensitivity. Lysosomal photodestruction of MDR cells overexpressing the
key MDR efﬂux transporters ABCG2, ABCB1 or ABCC1 resulted in 10- to 52-fold lower IC50 values of various IAs, thereby
restoring parental cell sensitivity. Finally, in vivo application of this photodynamic therapy strategy after i.v. injection of IAs in
human ovarian tumor xenografts in the chorioallantoic membrane model revealed selective destruction of tumors and their
associated vasculature. These ﬁndings identify lysosomal sequestration of IAs as an Achilles heel of MDR cells that can be
harnessed to eradicate MDR tumor cells via lysosomal photodestruction.
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Imidazoacridinones (IAs; Supplementary Figure 1) are hydro-
phobic weak base cytotoxic ﬂuorochromes that display
considerable antitumor activity towards murine and human
malignant cell lines in vitro,
1 and against breast- and
colon adenocarcinomas in vivo.
2 The marked similarity in
the chemical structure between IAs and the established
topoisomeraseIIinhibitormitoxantrone,suggestedacommon
cellular drug target. Indeed, previous studies have shown
that IAs block topoisomerase II activity
1 and stimulated
the in vitro formation of topoisomerase II-cleavable com-
plexes. Moreover, previous studies have shown that
IAs, which harbor a planar IA core, are capable of DNA
intercalation.
3
The frequent emergence of multidrug resistance (MDR) to
structurally and functionally unrelated anticancer drugs,
is a major impediment to curative cancer chemotherapy.
4–9
ATP-driven MDR efﬂux transporters belong to the large
ATP-binding cassette (ABC) superfamily of transporters that
include ABCB1 (P-gp), ABCC1 (MRP1) and ABCG2 (BCRP).
Overexpression of these efﬂux pumps results in the expulsion
of a multitude of chemotherapeutic drugs, thereby leading to
acquisition of a broad-spectrum drug resistance phenotype
known as MDR. As MDR remains a major obstacle to
successful cancer chemotherapy, there is a burning need to
develop new strategies to overcome MDR phenomena.
Taking advantage of the increased number of lysosomes in
MDR cells, we here developed an IAs-based photoactivated
pharmacological Trojan horse approach to eliminate MDR
cancer cells in vitro and in vivo. This strategy is based on the
efﬁcient sequestration of IAs inlysosomes. Upon photoactiva-
tion, reactive oxygen species (ROS) rapidly form, resulting in
lysosomal rupture and tumor cell lysis. In vivo photodynamic
therapy (PDT) experiments, based on the selective photo-
destruction of targeted tissue
10 further established that this
strategy is endowed with a potent capability to destroy human
tumor xenografts and their associated vasculature.
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IAs speciﬁcally accumulate in lysosomes. Recently we
have shown that IAs (Supplementary Figure 1), including
C-1330, C-1375 and C-1379, are not recognized by ABCG2,
whereas their hydroxyl-containing homologs (e.g., C-1311)
are readily expelled by this multidrug efﬂux pump.
11 Hence,
on the basis of their hydrophobic weak base nature and their
structural similarity to acridine orange, an established
ﬂuorophore known to concentrate within lysosomes, we
hypothesized that these IAs may also accumulate within
acidic organelles such as lysosomes. We therefore exposed
parental A549 cells and their ABCG2-overexpressing
MDR subline A549/K1.5
11 to C-1330 (green ﬂuorescence)
and LysoTracker red (red ﬂuorescence), an established
viable lysosomal marker. Cells were counterstained with the
supravital dye Hoechst 33342 (blue ﬂuorescence). Both cells
displayed co-localization of the red and green ﬂuorescence,
resulting in an orange signal in the merged photographs
(Figures 1a–f). Identical results were obtained with the IAs
C-1375 and C-1379 (data not shown). Moreover, we
observed a sevenfold increase in lysosomes’ ﬂuorescence
(i.e., an increase in the number and volume of lysosomes)
in MDR A549/K1.5 cells (4500±937a.u./cell), relative
to parental A549 cells (600±317a.u./cell) as determined
by LysoTracker red staining and quantiﬁcation using the
EZ-Quant software (EZ-Quant, Tel-Aviv, Israel) (Figure 1g).
Viable staining of the mitochondrial marker MitoTracker red
(red ﬂuorescence) in A549 cells excluded the possibility of
C-1330 localization in mitochondria (Supplementary Figure 2).
We postulated that the acidic pH of lysosomes is the driving
force for the marked compartmentalization of IAs in lysosomes.
We hence used two independent approaches to alkalinize
lysosomes: ammonium chloride, a weak base lysosomotropic
alkalinization agent and baﬁlomycin A1, a potent inhibitor of
H
þ-ATPase (i.e., vesicular ATPase). Following preincubation
ofA549(Figures2a,cande)andA549/K1.5cells(Figures2b,d
andf)withammoniumchloride(Figures2candd)orbaﬁlomycin
A1 (Figures 2e and f), subsequent exposure to C-1330 did not
result in lysosomal accumulation of C-1330. Interestingly, under
these conditions, C-1330, which bears a planar acridone ring
structure that is typical of various DNAdyes, brightlystained the
nuclei of both A549 and A549/K1.5 cells, in agreement with
previous studies.
3,11
Photosensitization of C-1330-treated cells results in rapid
lysosomal destruction mediated by ROS. S w i t c h i n go nt h e
light of the ﬂuorescence microscope resulted in a rapid
destruction and disappearance of ﬂuorescent lysosomes in
C-1330-treated cells (Supplementary Movies 1 and 2). These
lysosomal bursts were visible as multiple asynchronous
ﬂashes in both A549 and A549/K1.5 cells and resulted in the
disappearance of all ﬂuorescent lysosomes over a period of a
few minutes at the applied conditions. The disappearance of
lysosomes was accompanied by a simultaneous gradual
increase in nuclear ﬂuorescence. We hypothesized that the
rapid rupture of lysosomes and consequent release of C-1330
was due to an intrinsic photosensitizing activity of C-1330.
Photosensitizers have their destructive activity often through
the formation of ROS, which may be responsible for lysosomal
membrane lysis. Using direct detection of the luminescence
centered at 1270nm, we measured the generation of singlet
oxygen using C-1375 and C-1379 after pulsed excitation with
355nm laser radiation in acetonitrile and DMSO (Supplementary
Figure 3A). Measurable luminescence with lifetime of the order of
3ms was only detected in samples that were saturated with either
oxygen or air. The lifetime of the luminescence was consistent
with the reported lifetime of singlet oxygen in this solvent.
12
Moreover, using electron paramagnetic resonance (EPR)-spin
trapping and 5,5-dimethyl-1-pyrroline N-oxide (DMPO) as a spin
trap, we observed photogeneration of superoxide anion by both
Figure 1 Co-localization of C-1330 and LysoTracker red in lysosomes in A549
and A549/K1.5 cells. Parental A549 (a–c) and their MDR subline A549/K1.5 (d–f)
were viably stained with Hoechst 33342 (blue nuclear ﬂuorescence) along with
either100nMLysoTrackerred for 1h (red ﬂuorescence; a, and d)o r1 0mM C-1330
(green ﬂuorescence; b, and e) for 30min. Viable cell staining and quantiﬁcation of
the number of red ﬂuorescent lysosomes per cell were carried out by ﬁrst staining
with100nMLysoTrackerredfor1h(g)followedbylysosomecountinginatleast25
cells from each of three independent experiments using the EZ-Quant software.
Invertedﬂuorescencemicroscopyanalysisofviablecellstainingwas performedata
magniﬁcation of  630
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Cell Death and DiseaseC-1375 and C-1379 in a mixture of DMSO and H2O( 9 : 1 ) ;
Supplementary Figure 3B shows the EPR spectra of the DMPO
spin adduct that evolved with irradiation of the samples in the
resonant cavity. The EPR signal of the DMPO spin adduct
became much stronger in the presence of 1mM NADH.
Simulation of the EPR signal using magnetic parameters
commonly used for the DMPO-OOH adduct, is fully consistent
with the generation and spin trapping of superoxide anion. The
accumulation of DMPO-OOH with irradiation time for C-1375
and C-1379 in the absence or presence of NADH is shown in
Supplementary Figures 3A and B respectively. Whereas, the
accumulation of DMPO-OOH with irradiation time for riboﬂavin
was determined in the presence of EDTA (Supplementary
Figures 3B). From such data one can calculate relative rates of
the spin adduct formation in samples of the studied compounds
in comparison with riboﬂavin/EDTA, which is a known generator
of superoxide anion. It is evident from these results that these
IAs can generate singlet oxygen and superoxide anion upon
photoexcitation, particularly in the presence of an electron donor
such as NADH. Due to the ability of superoxide anion to
dismutate, it can be postulated that hydrogen peroxide will also
be generated after photoexcitation of IAs. These results suggest
that IAs-dependent lysosomal photodestruction is mediated by
the generation of ROS, which presumably leads to the rapid
rupture of the lysosomal membrane.
Photosensitization markedly enhances the cytotoxic
effect of IAs and overcomes MDR. We next explored the
impact of photosensitization of C-1330-loaded lysosomes on
cell viability. Monolayers of A549 and A549/K1.5 cells
(Figures 3a and b, respectively) were ﬁrst incubated with
C-1330, washed with drug-free medium, subjected to light
from the ﬂuorescence microscope and further incubated
for 48h. Light microscopy of Crystal Violet-stained cells
revealed that cells in light-exposed areas were completely
lysed. On the basis of these results and based on the
markedly increased number of lysosomes per ABCG2-
overexpressing MDR A549/K1.5 cell, we further explored
the hypothesis that MDR cells may consequently become
highly sensitive to the cytotoxic effect elicited by IAs upon
lysosomal photodestruction, resulting in the overcoming of
MDR. To this end, we ﬁrst determined the cytotoxic activity of
C-1330 in A549 and A549/K1.5 cells (Figures 3c and d,
respectively) in the presence or absence of photo-
sensitization. Illumination of C-1330-loaded cells resulted
in a 6- and 14-fold decrease in the IC50 values in A549
and A549/K1.5 cells, thereby resulting in an equal
C-1330 sensitivity in both cell lines (Table 1).
We expanded these ﬁndings to other IAs; photosensitiza-
tion markedly enhanced the cytotoxic activity of C-1375 and
C-1379 in A549 and A549/K1.5 cells by 10–32-fold, relative to
nonilluminated cells (Table 1). These results prompted us to
further expand the scope of the cytotoxic impact of IAs upon
photoexcitation to ABCB1 (P-gp)-overexpressing MDR non-
small-cell lung cancer SW1573/2R160 cells and ABCC1
(MRP1)-overexpressing ovarian carcinoma 2008/MRP1
cells (Table 1). Photosensitization of C-1375-loaded MDR
SW/2R160 and 2008/MRP1 cells resulted in a 13–51-fold
decrease in the IC50 of C-1375, whereas their parental cells
were sensitized by factors of 24–36-fold. Remarkably, in the
absence of illumination, these MDR cells displayed IC50
valuesintherange of3.3–5.5mM,whereasphotosensitization
decreased the IC50 values to as low as 90–330nM; we thus
achieved a signiﬁcant increase in parental cell sensitivity in
three different types of MDR cancer cells.
To further strengthen the current ﬁnding that cell death
occurs via lysosomal photodestruction we also evaluated the
cytokskeletal structure of cells before or after lysosomal
photodestruction by following F-actin using the well-estab-
lished Texas Red-Phalloidin conjugate (Figures 3e and f).
Phalloidin is a bicyclic peptide belonging to a family of toxins
isolated from the deadly Amanita phalloides and is widely
used in ﬂuorescence imaging applications to selectively label
F-actin. Importantly, incubation with C-1330 followed by
illumination led to lysosomal photodestruction, which resulted
in highly damaged cells that were devoid of their cytoplasmic
content as well as their actin cytoskeleton and only showed
deformed residual cytoskeletal structure that was present in
the cell’s perimeter (Figure 3f). In contrast, cells exposed to
C-1330 in the absence of illumination retained a normal actin
cytoskeleton (Figure 3e).
Figure 2 Lysosomotropic alkalinization agents abolish intralysosomal accumu-
lation of C-1330. A549 (a, c and e) and A549/K1.5 cells (b, d and f) were
preincubated either with the lysosomotropic agent ammonium chloride (10mM) for
30min (c and d), with baﬁlomycin A1 (1mM) for 1h (e and f) or with none (a and b),
following which cells were further incubated for 30 additional min with C-1330
(10mM).Cellswerethenanalyzedbyﬂuorescencemicroscopyat amagniﬁcation of
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Cell Death and DiseaseChloroquine induces a marked increase in both the
number and volume of lysosomes resulting in enhanced
C-1330 cytotoxicity upon photosensitization. Given the
remarkable cytotoxicity elicited by various IAs on tumor cells,
we explored the possibility of enhancing the number and
volume of lysosomes in tumor cells. Previously it was shown
that chloroquine, an anti-malarial and lysosomotropic agent,
increased the number and volume of lysosomes in tumor
Figure3 PhotoexcitationofC-1330-loadedA549andA549/K1.5cells.CrystalVioletstainingofC-1330-loadedcellswasfollowedbyexposuretoconﬁnedbluelight.A549
(a) and A549/K1.5 (b) cells were grown to half conﬂuence and loaded with 10mM C-1330 for 1h. Under the light microscope, a conﬁned zone of the cell monolayers was
exposed for 1min to a pulsed blue light beam (lex¼470nm with a measured ﬂuence of B180W/m
2). After 48h, monolayers were ﬁxed with methanol, stained with Crystal
Violet and analyzed by light microscopy at an  8 magniﬁcation. Cellular growth inhibition by C-1330 was determined as follows: logarithmically growing A549 cells (c) and
their MDR A549/K1.5 subline (d) were exposed to various concentrations of C-1330 for 2h. To evaluate the effect of illumination on the cytotoxicity of C-1330, cells were
divided into illuminated (1h constant illumination which yielded a total ﬂuence of 5J/cm
2) and nonilluminated control cells. Cellular viability was determined using a Cell
Proliferation Kit (XTT). Values depicted represent means±S.D. of at least three independent experiments. The F-actin cytoskeleton was evaluated with Texas Red-X-
Phalloidin in monolayer A549 cells; following 30min incubation with 10mM C-1330 without illumination (e) or 2h after photosensitzation (f), cells were incubated with Texas
Red-X-Phalloidin and the cytoskeleton was analyzed by a ﬂuorescence microscope as detailed in Materials and Methods. Note the highly damaged hollow cells that lost the
cytoplasmic cytoskeletal structure due to lysosomal photodestruction after incubation with C-1330 and illumination, whereas cells incubated with C-1330 in the absence of
illumination retained their intact cytoskeleton
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Cell Death and Diseasecells.
13 Fluorescence microscopy analysis after staining with
LysoTracker red revealed that exposure of A549 cells to
20mM chloroquine for 24 (compare Figure 4c with 4a) or 48h
(compare Figure 4e with 4a) resulted in a marked dose-
dependent increase in the number and volume of lysosomes
(Figure 4g); quantiﬁcation using EZ-Quant software revealed
an increase of 8.4- and 21.7-fold, respectively, in lysosomal
ﬂuorescence as compared with untreated control cells. We
hence explored the impact of chloroquine pretreatment on
C-1330 sensitivity in the presence and the absence of light
exposure by growth inhibition assays. Consistent with the
increased number and volume of lysosomes, chloroquine
induced a marked time- and dose-dependent resistance of
parental A549 cells to C-1330, in the absence of
photosensitization; upon illumination, cells became 23- to 49-
fold more sensitive to C-1330, compared with the 6-fold photo-
sensitization in the absence of chloroquine (Supplementary
Table 1). These results indicate that chloroquine, currently used
to treat malaria and rheumatoid arthritis, may be applied to
increase the number and volume of lysosomes following which
tumor cells may be efﬁciently eradicated by photosensitization
of IA-loaded lysosomes.
In vivo antitumor activity of IAs using tumor
xenografts. C-1375 and C-1379 showed similar
spectroscopic characteristics with absorbance in the range
340–500nm; their normalized ﬂuorescence spectra
are shown in Figure 5a. Both IAs emitted an intense
ﬂuorescence when excited at 444nm with maximal
emission at 553–554nm. Intravenous injection of these IAs
into the chicken CAM model, followed by photosensitization
produced a photodynamic vaso-occlusive activity for both
compounds. When injected at a low dose (1mg/embryo;
Figure 5b), the capillary network was massively occluded,
whereas larger blood vessels remained perfused (see
representative ﬂuorescence angiographies taken 24h post-
PDT in Figure 5c). Application of light alone did not induce a
vaso-occlusive effect (data not shown). At a higher dose
(100mg/embryo), all blood vessels and capillaries were
occluded within the illuminated area (Figure 5d).
Interestingly, the uptake of IAs in lining endothelial cells
was observed during and after PDT (Figure 5e), thereby also
leading to vascular damage (Figure 5f). Furthermore,
administration of IAs to the CAM grafted with human
ovarian A2780 tumors followed by PDT, resulted in
massive destruction of the tumor vasculature, already 24h
post-treatment (Figures 5g and h). A second PDT treatment
was applied to the same tumors 24h after the ﬁrst treatment.
As visualized 24h after the repeated PDT, almost all tumor
vasculature was destroyed and extensive vascular
dysfunction was observed, as revealed by the profound
leakage of FITC-dextran from the vasculature (Figures 5i and
j). This was also accompanied by massive destruction of the
ovarian tumor xenografts.
Discussion
Our current ﬁndings show that the achievement of an IAs-
dependent lysosomalphotodestructionintumorcellsrelies on
the striking sequestration of IAs in lysosomes. Several lines of
evidence support the differential compartmentalization of IAs
within lysosomes of tumor cells: (i) parental A549 and their
ABCG2-overexpressing MDR subline displayed co-localiza-
tion of C-1330 and the established lysosomal marker,
LysoTracker red; (ii) alkalinization of the acidic lysosomal
pH either with baﬁlomycin A1, a potent inhibitor of lysosomal
H
þ-ATPase, or ammonium chloride, an established
weak base (pKa¼9.25) lysosomotropic alkalinization agent,
resulted in the complete abrogation of lysosomal C-1330
accumulation. Previous studies have demonstrated that
treatment with baﬁlomycin A1 and ammonium chloride
increase the intralysosomal pH from 4–5 to 6.5–7.0.
14 Hence,
the driving force for lysosomal sequestration of IAs is the
acidic lysosomal pH and the consequent irreversible entrap-
ment of lAs via protonation; and (iii) it is well documented
15,16
that hydrophobic weak base chemotherapeutics, such as
anthracyclines, Vinca alkaloids and other cytotoxic agents,
includingacridone-basedﬂuorescentcompounds,thelatterof
which are structurally related to IAs, markedly accumulate
within acidic lysosomes; a hallmark example is acridine
orange, a bona ﬁde lysosomal marker widely used to
ﬂuorescently label lysosomes in viable cells.
17 Thus, the
organelle that predominantly compartmentalizes IAs in these
cancer cells is the lysosome. However, one cannot exclude
the possibility that alternative intracellular acidic vesicles such
Table 1 Growth inhibitory effects of various IAs on parental carcinoma cells and their MDR sublines
LD50 (nM) Fold Survival at 3000nM
a (%)
Drug Cell line Control Illumination Sensitization Control Illumination Delta
C-1330 A549 5023±716 842±208 6 72±54 3 ±62 9
A549/K1.5 12269±1119 850±23 14 87±42 8 ±15 9
C-1379 A549 6349±867 199±31 32 60±12 ±0.3 58
A549/K1.5 15192±580 747±45 20 82±47 ±0.1 75
C-1375 A549 3054±260 212±29 14 50±33 ±24 7
A549/K1.5 5264±877 541±56 10 70±53 ±0.6 67
SW1573 5535±596 233±52 4 6 8 ±61 1 ±25 7
SW1573/2R160 4384±125 330±56 13 74±32 4 ±45 0
2008 3280±345 90±93 6 7 2 ±0.8 11±46 1
2008/MRP1 5115±889 101±0.1 51 80±21 3 ±36 7
Abbreviations: IAs, imidazoacridinones; LD50, 50% lethal dose; MDR, multidrug resistance
aConcentration chosen with the highest delta of % survival between illuminated and nonilluminated cells
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Cell Death and DiseaseFigure 4 Treatment with the antimalarial chloroquine induces a marked increase in both the number and volume of lysosomes. A549 cells were seeded on glass cover
plates, allowed to attach and then exposed to 20mM chloroquine for 24 (c) and 48h (e), whereas control cells were not treated with chloroquine (a). The cytotoxic effect of
C-1330 to chloroquine-free control cells (b), cells exposed to 20mM chloroquine for 24 (d)o r4 8h( f) in the absence or presence of illumination was determined by the XTT
assayas describedin Figure3legend.Thedose-andtime-dependent effectofincubationwith chloroquineon theincreasednumberof lysosomes per A549cellas compared
withnontreatedcellswasdeterminedbyﬂuorescencemicroscopyfollowingstainingwiththeviablelysosomalmarkerLysoTrackerred(redﬂuorescenceinchloroquine-treated
cells) (g) as detailed in Materials and Methods. Note that for the sake of quantiﬁcation accuracy, the red lysosomal ﬂuorescence of LysoTracker was converted to a yellow
ﬂuorescence. Note the marked increase in the number and volume of lysosomes upon exposure of A549 cells to increasing concentrations of chloroquine as well as to
prolonged incubation times. Live detection of nuclei was achieved by staining with 1mg/ml Hoechst for 10min before imaging
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Cell Death and Diseaseas recycling endosomes, trans-Golgi network and secretory
vesicles could also contribute to sequestration of IAs.
18
Ourresults suggestthatanincreasednumberoflysosomes
is a key determinant of cell defense and consequent drug
resistance against hydrophobic weak base cytotoxic agents
including IAs that may reach their cellular target, topoisome-
rase II and DNA in the case of IAs. First, ABCG2-over-
expressing A549/K1.5 cells that displayed a marked increase
in the number of lysosomes were 2.4-fold more resistant to
C-1330 and C-1379, both of which are not recognized as
drug efﬂux substrates by ABCG2. Second, the dramatic
chloroquine dose-dependentinduction of increased lysosome
volume and number in parental A549 cells resulted in a
consistent increase of 3–7-fold in C-1330-resistance. Hence,
it is likely that epithelial and endothelial cells exposed to body
ﬂuids containing various toxicants have evolved to acquire
larger number of lysosomes as means of cell defense against
stress cues and cytotoxic agents including lipid-soluble weak
base cytotoxins.
19–21 Thus, as MDR cells are known to
contain an increased number of lysosomes per cell, targeting
MDR cells via lysosomal photodestruction using weak base
photosenstizers may be readily seen as a pharmacological
Achilles heel, and thus used as a Trojan horse approach to
eradicate MDR tumor cells.
The following evidence supports the choice of targeting
MDRcancercellsviaIAs-dependentlysosomalphotodestruc-
tion: (i) the luminal pH of lysosomes of various MDR tumor
cells was found to be markedly more acidic than their parental
counterparts, hence increasing the pH gradient between the
cytoplasm and lysosomes;
22,23 it is possible that the various
Figure 5 PDT after i.v. IA injection in the CAM vasculature and in tumor grafted CAMs. (a) Emission and excitation spectra of C-1379. (b) IA ﬂuorescence angiography
before IA-PDT (1mg/embryo, lex¼420±20nm). The bar in panel b denotes 500mm. (c) FITC-dextran angiography (lex¼470±20nm, lem 4520nm), 24h after PDT
(light dose 20J/cm
2, irradiance 70mW/cm
2). (d) IA ﬂuorescence angiography taken before IA-PDT (100mg/embryo, (lex¼420±20nm), right after (e; inset shows the
magniﬁcation of IA in the endothelial lining after PDT) and 24h (f) after PDT (light dose 20J/cm
2, irradiance 270mW/cm
2) visualized by FITC-dextran angiography
(lex¼470±20nm, lem 4520nm). Tumor grafted CAMs, 24h post IA-PDT of ovarian carcinoma on the CAM shown by ﬂuorescence angiography (g, FITC-dextran
angiography, lex¼470±20nm, lem 4520nm) and white light camera (h). The same tumor 48h after the second IA-PDT visualized by FITC-dextran angiography (i) and
white light camera (j). Black zones represent avascular areas
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Cell Death and DiseaseMDR cell lines studied here also harbor more acidiﬁed
lysosomes than their parental cells. This would result in an
increased capacity of these MDR cells to sequester hydro-
phobic weak base cytotoxic agents including IAs within
lysosomes; (ii) it has been shown that various MDR
tumor cells display a more basic cytoplasmic pH than their
drug-sensitive parental counterparts and nonmalignant
cells.
18,22,23 Consequently, the pH gradient between the
cytoplasm and lysosomes will further increase, hence enhan-
cing the capacity of lysosomes to concentrate hydrophobic
weak base cytotoxic agents. Consistently, the MDR tumor
cells employed here could comply with this increased DpH
between the lysosome and the cytoplasm, thereby further
enhancing the capacity of lysosomes to highly sequester IAs.
These predictions that the MDR cells we employed here
possess lysosomes that are more acidic and presumably
have a more basic cytoplasmic pH are supported by the fact
that apart from the increased number of lysosomes in A549/
K1.5 cells, each lysosome of these MDR cells displayed a
markedly increased accumulation of the ﬂuorescent IAs,
when compared with the rather faint ﬂuorescence signal
emitted from parental cell lysosomes; and (iii) one of the
hallmarks of malignant tumors and metastatic cancers is
acidosis of their tumor microenvironment;
24 this is attributable
to lactic acid production via anaerobic glycolysis of cancer
cells (known as the Warburg phenomenon) that proliferate
under hypoxic conditions. Hence, this acidosis of the tumor
microenvironment implies that hydrophobic weak base
chemotherapeutics would preferentially accumulate in solid
tumors than in healthy tissues. This would present an
excellent opportunity for intratumoral sequestration, which
could be then followed by PDT, ROS generation and tumor
destruction. This should result in enhanced therapeutic
efﬁcacy in the absence of severe damage to healthy tissues.
In fact, this has been one of the major underlying principles of
the selectivity of the concentration of the cytotoxic photo-
sensitizer effect of PDT agents used against malignant
cancers.
25
Our ﬁndings suggest that the mechanism underlying the
damage inﬂicted by illumination, rapid lysosome rupture and
cell death is mediated through rapid production of ROS. First,
using established methodologies we showed that photoexci-
tation of IAs results in the formation of singlet oxygen and
superoxide anion. Second, the presumed mediation of cell kill
by ROS in our IA-loaded MDR cells undergoing lysosomal
photodestruction, is in accord with the widely accepted
mechanism of cytotoxicity of various photosensitizers
used in PDT including protoporphyrins; upon illumination,
these photosenstizers undergo ﬂuorescence excitation
(i.e., from the singlet excited state), and/or transferring their
excitation (energy) to the triplet state molecular oxygen via
intersystem crossing. The latter undergoes collisional energy
transfer with ground state O2
3S to yield reactive O2
1D. Other
ROS can be also produced by the excited photosensitizer.
26
Recent studies have determined that ROS production in a
PDT scheme using photoexcited protoporphyrin IX induced
an essentially instantaneous production of ROS with a
remarkable time rate constant of 0.0044min
 1.
27 Thus, the
rapid lysosomal photodestruction in our MDR tumor cells is
consistent with this rate constant of ROS production.
Singlet oxygen radicals and ROS are extremely detrimental
to biomolecules such as proteins, nucleic acids and
biomembranes and result in rapid cell death. Hence, the
abrupt lysis of IA-loaded lysosomes upon photoexcitation is
consistent with the rapid generation of ROS. The consequent
intracellular rupture of lysosomes with the abrupt introduction
of their harmful highly acidic content containing a spectrum of
extremely potent hydrolytic enzymes would certainly lead to
rapid digestion of polypeptides, nucleic acids and biomem-
branes and consequent cell lysis. This is supported by our
Crystal Violet staining of monolayer cells undergoing lysoso-
mal photodestruction in which complete cell lysis occurred
with residual cytoskeletal scaffolds. In summary, the differ-
ential quantitative retention of the IAs photosensitizers in
lysosomes in MDR cells could be used as an Achilles heel
strategy to eradicate MDR cells. Interestingly, despite the
photoexcitation, the harsh acidic pH and ample hydrolytic
activities of the lysosomes, IAs, unlike many PDT agents, did
not undergo photolysis and apparently retained their structure
and function as they readily bind to DNA upon lysosomal
rupture. This may be an added value in inﬂicting a cytotoxic
effect upon neighbor nonilluminated malignant cells, tumor
microenvironment and vasculature.
Materials and Methods
Chemicals. LysoTracker red DND99 and MitoTracker red CMXRos were
purchased from Invitrogen (Carlsbad, CA, USA). Ammonium chloride, acridine
orange, Crystal Violet and chloroquine were from Sigma-Aldrich (St. Louis, MO,
USA). Baﬁlomycin A1 was purchased from Enzo Life Science (Farmingdale, NY,
USA). IAs were synthesized by Drs. M Cholody, B Horowska and M Konieczny in
the Department of Pharmaceutical Technology and Biochemistry, Gdansk
University of Technology, Gdansk, Poland.
Cell culture. Non-small-cell lung cancer A549 cells and their ABCG2-
overexpressing A549/K1.5 subline, ovarian carcinoma 2008 cells and their stable
MRP1 transfectant 2008/MRP1, non-small lung cancer cell line SW1573 and its ABCB1-
overexpressing subline SW1573/2R160 were maintained in RPMI-1640 medium (Gibco,
Paisley, UK) supplemented with 10% fetal bovine serum, 2mM glutamine, 100mg/ml
penicillin and streptomycin (Biological Industries, Beth-Haemek, Israel) in a humid
atmosphere containing 5% CO2 at 371C. A549/K1.5 and SW1573/2R160 cells were
grown in medium containing 1.5mM C-1305
28 and 100nM doxorubicin, respectively.
Cells were cultured in drug-free conditions for a week before any analysis.
Live cell imaging and quantiﬁcation of lysosomes. A549 and A549/
K1.5 cells were grown for 24h in 35mm FluoroDish (World Precision Instruments,
Sarasota, FL, USA). For C-1330 localization studies, cells were viably stained with
10mM C-1330 for 30min along with either 100nM LysoTracker red or 100nM
MitoTracker red for 1h at 371C. The established viable lysosomal marker
LysoTracker red was used to quantify the number/volume of lysosomes per cell in
parental tumor cells and their MDR sublines overexpressing speciﬁc MDR efﬂux
transporters of the ABC superfamily. Cellular LysoTracker red ﬂuorescence was
followed with a Zeiss Axiovert 200 inverted ﬂuorescence microscope (Carl Zeiss,
Oberkochen, Germany) equipped with a digital camera using a red Cye 3 ﬁlter
(lex¼545nm and lem¼605nm). Quantiﬁcation of red ﬂuorescence of lysosomes
per cell was undertaken by evaluating at least 25 LysoTracker red-stained cells in
each of at least three independent experiments using the EZ-Quant statistical
analysis software (version 1105). Inverted ﬂuorescence microscopy analysis of
viable ﬂuorescent cells was performed at a magniﬁcation of  630.
Beforeﬂuorescenceimaging,cellswereincubatedinmediumcontaining2mg/ml
Hoechst 33342 for 10min. For nuclear staining, A549/K1.5 cells were incubated for
1h with Hoechst 33342 and 10mM fumitremorgin C (FTC) to prevent efﬂux of the
DNA dye by ABCG2. Live cell imaging was performed using a Zeiss Axiovert 200
inverted ﬂuorescent microscope (Carl Zeiss).
Chloroquine treatment. A549 cells were seeded in 96-well plates at 500 or
1000 cells/well (for 24h or 48h treatment, respectively; 0.1ml medium/well).
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100mM) or 48h (20mM). For cytotoxicity assays, C-1330 concentrations ranging
from 10nM to 100mM were added for two additional hours. For viable ﬂuorescent
labeling of lysosomes and nuclei, LysoTracker red DND 99 (100nM) was added for
1h before ﬂuorescence imaging, following which Hoechst 33342 (2mg/ml) was
added 10min before imaging. Cells were ﬁrst analyzed with a Zeiss Axiovert
200 inverted ﬂuorescence microscope (Carl Zeiss) equipped with a digital camera
and then illuminated using a GFP þ DsRed ﬁlter (lex¼470nm; lem¼512nm
and630nm;thisisalongpassﬁlterwhichtransmitslongerwavelengthsoverawide
spectrum). LysoTracker Red and MitoTracker Red CMXRos were followed using a
red ﬁlter Cye 3 (lex¼545nm and lem¼605nm), whereas a DAPI ﬁlter
(lex¼365nm and lem¼445±50nm) was used to follow nuclear staining with
Hoechst 33342. Light intensity was maintained at 12.5% of the maximum.
Light intensity in the illuminated cell monolayer zone was B3W/m
2 and the light
dosage for 30s was 90J/m
2. The magniﬁcation used was  630.
Crystal Violet staining. Cells were grown to conﬂuence on glass bottom
platesandincubatedwith10mMC-1330for30min.Followingmediumrefreshment,
plates were exposed to 1min constant excitation at 470nm using a Zeiss inverted
ﬂuorescence microscope. Cells displaying lysosomal photodestruction were further
incubatedfor48hat371C,thenwashedtwicewithPBS,ﬁxedwith70%andstained
with a dilute (1:5) Crystal Violet solution in PBS. Stained monolayer cells were then
examined and photographed using a Leica M80 binocular at a  8 magniﬁcation
(Leica Microsystems GmbH, Wetzlar, Germany).
Cytotoxicity assays. Cells were seeded in 96-well plates (2 10
4 cells in
90ml growth medium/well), incubated for 24h and exposed to increasing
concentrations of IAs. Following 2h incubation, the drug-containing medium was
replaced by drug-free medium and cells were placed on an illuminator plate (Model
460 thin line series, S&S X-Ray Products Inc., Brooklyn, NY, USA) for 1h, hence
achieving a light dose of 5J/cm
2. Plates were then further incubated for 24h. Cell
viability was determinedusing the Cell Proliferation Kit (XTT) (Biological Industries).
Drug concentrations required to inhibit cell growth by 50% (IC50) in the absence or
presence of illumination, were determined from the cell survival curves. Results
presented are means of at least three independent experiments.
Spectroscopy assessment of IAs. C-1375 and C-1379 were dissolved in
DMSO(Sigma-Aldrich)anddilutedin0.9%NaCl.Absorptionspectrawererecorded
withatwo-beamVarianCaryUV-Vis-NIR500Scanspectrophotometerin1-cmlong
quartz cuvettes (Suprasil, Hellma, Mu ¨llheim, Germany) in the range of 350 to
750nm with an average scan speed of 600nm/min at room temperature. Steady-
state luminescence spectra were recorded with a luminescence spectrometer
(Perkin-Elmer, model LS50B, Wellesley, MA, USA).
Texas red-phalloidin staining. A549 cells were grown on coverslips in
24-well plates until conﬂuence was reached. Cells were then incubated with 10mM
C-1330 for 30min and exposed to light for 1min, resulting in lysosomal
photodestruction. Control cells were loaded with C-1330 but were not illuminated.
C1330-loaded cells were either ﬁxed and stained with Texas Red-X-Phalloidin (Life
Technologies,Carlsbad,CA,USA)withnoilluminationorstainedwithTexasRed-X-
Phalloidin 2h after light-induced lysosomal photodestruction. Cells were then
washed twice with PBS and ﬁxed by adding 4% formaldehyde for 10min in room
temperature. Following two additional washes with PBS, 0.1% Triton X-100 was
addedfor 10min andthen washedtwicetoremove TritonX-100.Blockingwas then
achieved using a solution of 20% skim milk and 2.5% fetal calf serum for 20min. At
this stage, 5ml of Texas Red–X phalloidin stock solution was added into 0.2ml of
PBS and incubated protected from light for 20min. The samples were ﬁnally rinsed
to remove excess Texas Red-X Phalloidin. Coverslips were removed gently from
wells and attached onto slides using Fluoromount-G. Fluorescent cells were
analyzed by a ﬂuorescence microscope at lex¼545nm and lem¼605nm.
Detection of superoxide anion and singlet oxygen. Photosensitized
formationofsuperoxideanionwasdetectedbyEPR-spintrappingusingDMPOasa
spin trap, as described previously.
29,30 IAs solutions containing 0.1M DMPO
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in DMSO/H2O (9:1) were
illuminatedina0.25-mmquartzcellwithintheresonantcavityofaBrukerEMEX-AA
EPR spectrometer (Bruker BioSpin, Rheinstetten, Germany) with 400–490nm light
derived from a Cermax PE300CE-13FM 300W lamp in air-cooled housing (Perkin
Elmer).Thislightsourcewasequippedwiththenecessarycombinationofcutoffand
band-pass ﬁlters. Relative yields of the photo-formation of superoxide anion by IAs in
the presence or absence of NADH, used as an auxiliary electron donor, were
determinedbycomparingratesoftheaccumulationofDMPO-OOHdeterminedforIAs
and for riboﬂavin with and without EDTA. Quantum yields for singlet oxygen
photogeneration by IAs were determined relative to that for Rose Bengal (RB) by
measuring time-resolved luminescence intensity in DMSO or acetonitrile solutions at
1270nm, after excitation of the compounds or RB at 355nm with microjoule 750ps
pulses generated by amicrochipNd:YAGlaser (Pulselas-P-1064-FC,Alphalas GmbH,
Goettingen, Germany), operating with 2–10kHz repetition rate. Near-infrared
luminescence was measured perpendicularly to the excitation beam in a photon-
counting mode
31 using a thermoelectric cooled NIR PMT module (model H10330-45,
Hamamatsu, Shizuoka, Japan) equipped with a 1100-nm cutoff ﬁlter and additional
selected narrow-band ﬁlters (NB series, NDC Infrared Engineering Ltd, Maldon, UK).
Data were collected using a computer-mounted PCI-board multichannel scaler
(NanoHarp 250, PicoQuant GmbH, Berlin, Germany).
In vivo PDT with IAs using the CAM model. Fertilized chicken eggs
(Animalco AG, Staufen, Switzerland) were incubated in a hatching incubator (65%
humidity, 371C) equipped with an automatic rotator (Savimat, Chauffry, France) as
described previously.
32 Brieﬂy, on embryo development day 11 (EDD 11), the hole
in the shell above the air pouch of the egg (made on EDD 3) was extended to a
diameter of B3cm in order to provide better access to the CAM for the
experiments.Eggswereplacedunder anepi-ﬂuorescencemicroscope(Eclipse600
FN, Nikon, Egg, Zurich, Switzerland). Subsequently, 100ml of IAs (C-1375 or
C-1379) at doses of 1mg/embryo or 100mg/embryo were administered into the main
vessel of the CAM through a 33-gauge needle ﬁtted to a 100ml syringe (Hamilton,
Reno, NV, USA). One minute later, the 0.02cm
2 area of the CAM was irradiated with
alightdoseof20J/cm
2(lex¼420nm),irradianceof70or270mW/cm
2.Thesitewas
photographed before and after the irradiation. Subsequently, the egg opening was
sealed with Paraﬁlm (Pechiney, Menasha, WI, USA) and the embryo was incubated
for 24h. The PDT-induced damage was assessed by ﬂuorescence angiography after
i.v. injection of FITC-dextran (20kDa, 25mg/ml; lex¼470nm and lem¼520nm)
andIndiaink(30ml/embryo)intotheextra-embryoniccavityaspreviouslydescribed.
33
IA treatment was performed with ﬁve eggs.
Tumor xenografts on the CAM and IA treatment with PDT. Human
A2780ovariancarcinomacellswereusedtoestablishtumorxenograftsintheCAM.
Tumor cells were suspended in medium containing 20% methocel (Sigma-Aldrich),
and 50ml drops (1 10
6cells/drop) were dispensed on the internal part of the lid of
a petri dish. After 24h, spheroids were harvested and placed on the CAM (EDD 7).
AtEDD11,C-1375andC-1379wereinjectedi.v.atadoseof12mg/embryo.PDTof
tumor xenografts was performed 1min later (lex¼420nm; light dose 34J/cm
2;
irradiance 70mW/cm
2). The PDT procedure was repeated 24h later. Tumors
were visualized by standard white light camera and subsequently by
FITC-dextran angiography, 24 and 72h after the ﬁrst PDT treatment.
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